Orleans Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q2 | – | Sell |
-8,044
| Closed | -$424K | – | 79 |
|
2017
Q1 | $424K | Sell |
8,044
-3,471
| -30% | -$183K | 0.3% | 69 |
|
2016
Q4 | $554K | Sell |
11,515
-14,491
| -56% | -$697K | 0.4% | 64 |
|
2016
Q3 | $1.4M | Buy |
26,006
+520
| +2% | +$28K | 0.97% | 47 |
|
2016
Q2 | $1.38M | Sell |
25,486
-6,256
| -20% | -$339K | 0.96% | 47 |
|
2016
Q1 | $1.61M | Buy |
31,742
+843
| +3% | +$42.7K | 1.21% | 37 |
|
2015
Q4 | $1.56M | Sell |
30,899
-8,330
| -21% | -$420K | 1.2% | 37 |
|
2015
Q3 | $1.89M | Sell |
39,229
-121
| -0.3% | -$5.81K | 1.5% | 29 |
|
2015
Q2 | $2.05M | Buy |
39,350
+3,741
| +11% | +$195K | 1.45% | 30 |
|
2015
Q1 | $2.05M | Buy |
35,609
+21,132
| +146% | +$1.22M | 1.34% | 35 |
|
2014
Q4 | $773K | Sell |
14,477
-26,419
| -65% | -$1.41M | 0.47% | 62 |
|
2014
Q3 | $2.35M | Buy |
+40,896
| New | +$2.35M | 1.16% | 41 |
|